Monoclonal Antibody Treatment – Bebtelovimab
Monoclonal antibodies are lab-created proteins that mimic the immune system’s ability to fight off viruses and diseases. Bebtelovimab is a monoclonal antibody therapy directed against SARS-CoV-2, designed to block the virus’ attachment and entry into human cells. Currently, Bebtelovimab is the only monoclonal antibody authorized for treatment of COVID-19.
This monoclonal antibodies treatment is shown to:
- Reduce the risk of hospitalization
- Reduce symptom severity
Price: enter zip below to see local pricing
*Cost is for the in-home service, medication is free